Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Craig Jordan

Showing results (91-100 of 218) with videos related to

Pageof 22
Sort By:
Expert Opinion on Pharmacotherapy|February 8, 2011
Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifeneSeung Sang Ko, V Craig Jordan
Cancer Prevention Research (Philadelphia, Pa.)|April 12, 2011
Paradoxical clinical effect of estrogen on breast cancer risk: a "new" biology of estrogen-induced apoptosisV Craig Jordan, Leslie G Ford
Methods in Molecular Medicine|February 24, 2006
Models of hormone resistance in vitro and in vivoJennifer MacGregor Schafer, V Craig Jordan
Trends in Molecular Medicine|January 30, 2002
Selective estrogen receptor modulators (SERMS) and their roles in breast cancer preventionWoo-Chan Park, V Craig Jordan
Steroids|December 16, 2006
Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancerV Craig Jordan, Angela M H Brodie
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Tamoxifen Decreases Mortality, but How?Poulomi Bhattacharya, Balkees Abderrahman, V Craig Jordan
Journal of the National Cancer Institute|August 8, 2002
Re: Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17 beta-estradiol and the two faces of Janus: sex steroids as mediators of both cell proliferation and cell deathV Craig Jordan, Hong Liu, Rita Dardes
Breast Cancer Research : BCR|October 29, 2003
Introducing a new section to Breast Cancer Research: endocrinology and hormone therapyV Craig Jordan, Bruce A J Ponder
Expert Review of Anticancer Therapy|March 11, 2017
Opportunities and challenges of long term anti-estrogenic adjuvant therapy: treatment forever or intermittently?Poulomi Bhattacharya, Balkees Abderrahman, V Craig Jordan
Breast Disease|August 19, 2006
Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs)Joan S Lewis-Wambi, V Craig Jordan
Pageof 22

Showing results (91-100 of 218) with videos related to

Sort By:
Pageof 22
Expert Opinion on Pharmacotherapy|February 8, 2011
Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifeneSeung Sang Ko, V Craig Jordan
Cancer Prevention Research (Philadelphia, Pa.)|April 12, 2011
Paradoxical clinical effect of estrogen on breast cancer risk: a "new" biology of estrogen-induced apoptosisV Craig Jordan, Leslie G Ford
Methods in Molecular Medicine|February 24, 2006
Models of hormone resistance in vitro and in vivoJennifer MacGregor Schafer, V Craig Jordan
Trends in Molecular Medicine|January 30, 2002
Selective estrogen receptor modulators (SERMS) and their roles in breast cancer preventionWoo-Chan Park, V Craig Jordan
Steroids|December 16, 2006
Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancerV Craig Jordan, Angela M H Brodie
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Tamoxifen Decreases Mortality, but How?Poulomi Bhattacharya, Balkees Abderrahman, V Craig Jordan
Journal of the National Cancer Institute|August 8, 2002
Re: Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17 beta-estradiol and the two faces of Janus: sex steroids as mediators of both cell proliferation and cell deathV Craig Jordan, Hong Liu, Rita Dardes
Breast Cancer Research : BCR|October 29, 2003
Introducing a new section to Breast Cancer Research: endocrinology and hormone therapyV Craig Jordan, Bruce A J Ponder
Expert Review of Anticancer Therapy|March 11, 2017
Opportunities and challenges of long term anti-estrogenic adjuvant therapy: treatment forever or intermittently?Poulomi Bhattacharya, Balkees Abderrahman, V Craig Jordan
Breast Disease|August 19, 2006
Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs)Joan S Lewis-Wambi, V Craig Jordan
Pageof 22